In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

What makes reading from a book better than reading from a screen? Phil and Georgie discuss this and teach you some useful vocabulary. And I’m Georgie. For me, there’s nothing like reading a book – I ...